tiprankstipranks
Trending News
More News >
N4 Pharma (GB:N4P)
:N4P
UK Market
Advertisement

N4 Pharma (N4P) Technical Analysis

Compare
5 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
4Neutral
5Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
N4 Pharma’s (N4P) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting N4 Pharma is a Sell.
N4 Pharma’s (N4P) 20-Day exponential moving average is 0.41, while N4 Pharma’s (N4P) share price is 0.45p, making it a Buy.
N4 Pharma’s (N4P) 50-Day exponential moving average is 0.42, while N4 Pharma’s (N4P) share price is 0.45p, making it a Buy.

N4 Pharma (N4P) Pivot Points

Aug 06, 2025, 01:47 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.30
0.35
0.40
0.45
0.50
0.55
0.60
Fibonacci
0.35
0.39
0.41
0.45
0.49
0.51
0.55
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

N4 Pharma (N4P) Moving Averages

Aug 06, 2025, 01:47 PM
Period
Simple
Exponential
MA5
0.44Buy
0.44Buy
MA10
0.41Buy
0.42Buy
MA20
0.39Buy
0.41Buy
MA50
0.42Buy
0.42Buy
MA100
0.43Buy
0.44Buy
MA200
0.52Sell
0.50Sell
N4 Pharma’s (N4P) 10-Day exponential moving average is 0.42, while N4 Pharma’s (N4P) share price is 0.45p, making it a Buy.
N4 Pharma’s (N4P) 100-Day exponential moving average is 0.44, while N4 Pharma’s (N4P) share price is 0.45p, making it a Buy.
N4 Pharma’s (N4P) stock price is 0.45p and N4 Pharma’s (N4P) 50-day simple moving average is 0.42, creating a Buy signal.
N4 Pharma’s (N4P) stock price is 0.45p and N4 Pharma’s (N4P) 100-day simple moving average is 0.43, creating a Buy signal.
N4 Pharma’s (N4P) stock price is 0.45p and N4 Pharma’s (N4P) 200-day simple moving average is 0.52, creating a Sell signal.

N4 Pharma (N4P) Technical Indicators

Aug 06, 2025, 01:47 PM
Name
Value
Implied Action
RSI (14)
79.11
Sell
STOCH (9,6)
66.67
Neutral
STOCHRSI (14)
66.67
Neutral
MACD (12,26)
<0.01
Sell
ADX (14)
27.40
Neutral
Williams %R
-33.33
Buy
CCI (14)
173.23
Sell
ATR (14)
0.06
-
Ultimate Oscillator
49.43
Neutral
ROC
18.42
Buy
N4 Pharma’s (N4P) Relative Strength Index (RSI) is 79.11, creating a Sell signal.
N4 Pharma’s (N4P) Trend Strength Indicator (ADX) is 27.40, creating a Neutral signal.
N4 Pharma’s (N4P) Commodity Channel Index (CCI) is 173.23, creating a Sell signal.
N4 Pharma’s (N4P) Price Rate of Change (ROC) is 18.42, creating a Buy signal.

FAQ

Is N4P a Buy, Hold, or Sell?
Based on N4P’s technical indicators, N4P is a Buy.
    What is N4P’s RSI (14)?
    N4P’s RSI (14) is 79.11, which suggests N4P is a Sell.
      What is N4P’s MACD?
      N4P’s MACD is <0.01, which suggests N4P is a Sell.
        What is N4P’s 5-day moving average?
        N4P’s 5-day moving average is 0.44, which suggests N4P is a Buy.
          What is N4P’s 20-day moving average?
          N4P 20-day moving average is 0.39, which suggests N4P is a Buy.
            What is N4P’s 50-day moving average?
            N4P’s 50-day moving average is 0.42, which suggests N4P is a Buy.
              What is N4P’s 200-day moving average?
              N4P’s 200-day moving average is 0.52, which suggests N4P is a Sell.
                What is N4P’s Williams % R (14)?
                N4P’s Williams % R (14) is -33.33, which suggests N4P is a Buy.
                  What is N4P’s CCI (14)?
                  N4P’s CCI (14) is 173.23, which suggests N4P is a Sell.
                    What is the share price of N4 Pharma?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis